Friday, May 12, 2023 10:15 AM – 12:15 PM ET Room 202A
Block Symposium
Immunometabolism and Anti-tumor Immunity
Chairs
- Jeffrey C. Rathmell, Vanderbilt Univ.
- Kyle K. Payne, Rutgers Cancer Inst. of New Jersey
Speakers
- Paola Cappello, Univ. of Turin, Italy, Iron-overload affects anti-tumor immune response in pancreatic cancer
- Joanina K. Gicobi, Mayo Clin., Resilient CD8+ T cells maintain a high cytotoxic capacity by balancing ROS and energy needs via ME1 upregulation
- Paramita Chakraborty, Medical Univ. of South Carolina, Sphingosine 1-phosphate / Acetyl CoA Carboxylase1 axis regulates the differentiation and function of tumor-associated myeloid-derived suppressor cells
- Hai Huang, Feinstein Inst. for Med. Res., Pre-operative exercise therapy suppresses colorectal liver metastases by triggering anti-tumor trained immunity of Kupffer cells
- Chuan-Teng Liu, China Med. Univ. Hosp., Taiwan, Immunometabolic modulation by targeting UCP2 and IL-17A boost anti-tumor immunity against pancreatic cancer
- Emilie L. Fisher, Vanderbilt Univ. Med. Ctr., Improving anti-tumor CD8+ T cell function through manipulating glutamine metabolism
- Meng-Han Wu, Univ. of Colorado Anschutz Med. Campus, Modulating T cell metabolism to improve CAR-T cell therapy success
